New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
08:34 EDTWFT, NOK, FIO, TGT, AMT, IGT, WMB, EOG, CCL, BHP, COV, MDT, BLUEOptions expected to be active
Options expected to be active: WFT MDT COV BHP CCL EOG WMB IGT AMT TGT FIO NOK BLUE
News For WFT;MDT;COV;BHP;CCL;EOG;WMB;IGT;AMT;TGT;FIO;NOK;BLUE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
September 23, 2014
06:07 EDTBHPBHP Billiton shedding 700 mining jobs in Queensland, Guardian reports
Subscribe for More Information
06:02 EDTIGTInternational Game partners with Ellen DeGeneres Show for new video slot machine
Subscribe for More Information
05:56 EDTMDT, COVTreasury, IRS announce plans to reduce inversion tax benefits
Subscribe for More Information
September 22, 2014
15:06 EDTCCLNotable companies reporting before tomorrow's open
Subscribe for More Information
12:28 EDTCCLCarnival technical notes ahead of earnings
In the past three months the shares have performed inline with the broader averages. The trend has been strongly up since the low of early August and the shares are trading near the 52-week high of $41.89. That high would be a highly probable upside objective on a positive surprise. On better than expected news that strongly exceeds expectations there would be room for a breakout in price. Next resistance levels as potential upside objectives depending on the degree of positive surprise would be at $42.67, $44.42, and $46.86. If the news fails to meet expectations, downside objectives could be at the following support levels: $38.24, $36.54, and $35.64. There is a small short-base in the shares which could exacerbate downside reactions in the event of a negative surprise.
09:32 EDTMDTMedtronic announces CE Mark, European launch for TYRX envelope
Medtronic has received CE, or Conformité Européenne, Mark for the TYRX Absorbable Antibacterial Envelope, which covers an implantable cardiac device to help stabilize the device after implantation and reduce surgical-site infections.
September 20, 2014
20:43 EDTWFTChesapeake, Weatherford seem attractive, Barron's says
Subscribe for More Information
September 19, 2014
11:25 EDTCOV, MDTSenators bring bill requiring companies to settle before inverting
U.S. Senators Sherrod Brown and Dick Durbin announced new legislation requiring corporations to "Pay What You Owe Before You Go" – settling their U.S. tax bill before relocating to a foreign country. "Everyone knows that before you leave a restaurant you have to settle your tab," Brown said. "Corporations shouldn’t get to play by different rules. While it is critical that we reach a long-term solution that reforms our international corporate tax code by implementing a global minimum tax and reducing the statutory tax rate, this bill is an immediate, commonsense measure to ensure businesses settle up before leaving the U.S." Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott (ABT), Medtronic's (MDT) acquisition of Covidien (COV) and Valeant's (VRX) proposed takeover of Allergan (AGN).
11:18 EDTCCLCarnival October volatility elevated into Q2 and outlook
Carnival October call option implied volatility is at 26, January is at 21; compared to its 26-week average of 23 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on September 23.
07:23 EDTNOKFCC to hold a roundtable
Open Internet Roundtable: Technological Aspects will consider the technical aspects of ensuring an Open Internet, including questions of scope, transparency, blocking, mobile networks, and reasonable network management and is being held at FCC Washington, D.C. offices on September 19 at 1:30 pm. Webcast Link
September 18, 2014
12:18 EDTMDTNY AG announces national settlement with Medtronic for Medicaid violations
Attorney General Eric T. Schneiderman announced that 46 states and the District of Columbia have reach a settlement agreement with Minnesota-based company Medtronic to resolve claims under the False Claims Act that Medtronic improperly induced physicians to recommend Medtronic devices to treat cardiac rhythmic disease. New York led a national team composed of members from Oregon, Texas and California to negotiate the settlement. The federal government settled its matter in May of this year...The agreement requires Medtronic to pay the settling states $362,362, which will go to those states’ Medicaid programs. The matter was brought by a whistleblower, Adolfo Schroeder, and was filed in U.S. District Court for the Eastern District of California. The Attorney General would like to thank Mr. Schroeder for bringing this matter to the government’s attention. Under the terms of the agreement, the New York Medicaid Program will receive $67,369.31. Reference Link
11:01 EDTTGTTarget to hire 70,000 seasonal workers in 2014, CNBC reports
Subscribe for More Information
07:38 EDTEOGUBS to hold a conference
Subscribe for More Information
September 17, 2014
16:01 EDTCOVCovidien raises quarterly dividend to 36c from 32c
Subscribe for More Information
10:00 EDTBHPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:08 EDTMDTMedtronic launches new Balloon Kyphoplasty Platform
Subscribe for More Information
07:43 EDTMDTBofA/Merrill to hold a conference
Subscribe for More Information
07:39 EDTAMTMorningstar to hold a conference
Management Behind the Moat Conference to be held in Chicago on September 17-18.
06:09 EDTMDTIntegra LifeSciences to acquire Medtronic instrumentation lines for $60M
Integra LifeSciences (IART) and Medtronic (MDT) announced an agreement in which Integra will acquire Medtronic's MicroFrance and Xomed manual ENT and laparoscopy instrumentation lines for approximately $60M in cash. Integra expects the transaction to close in Q4. Integra will acquire a portfolio of approximately 4,000 MicroFrance and Xomed manual ENT and laparoscopic surgical instruments, as well as the St. Aubin le Monial, France manufacturing facility. Sales from the products being acquired totaled approximately $30M, two-thirds of which were generated outside the U.S. Integra expects to record approximately $27M-$30M in revenue and approximately 10c of adjusted EPS in calendar 2015 from this acquisition. The earnings accretion should rise after the first year once certain sales transitions are complete. The company expects the acquisition to contribute less than $5M in revenue and be neutral to earnings in Q4. The transition and integration is expected to be completed by 2H15.
05:26 EDTBHPBHP Billiton downgraded to Underperform from Neutral at Exane BNP Paribas
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use